Resources | NITAG RESOURCE CENTER

2024 ∙ NACI

Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19

2023 ∙ JCVI

JCVI statement on the COVID-19 vaccination programme for autumn 2023 - updated on October 2023

2023 ∙ ATAGI

ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines

2023 ∙ NACI

Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19

2023

Routine vaccination programme against COVID-19 in the Netherlands

2023 ∙ ATAGI

ATAGI Update on the COVID-19 Vaccination Program

2023 ∙ ACIP

Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023

2023 ∙ NACI

Guidance on the use of COVID-19 vaccines in the fall of 2023

2023 ∙ NACI

NACI Interim guidance on the use of bivalent Omicroncontaining COVID-19 vaccines for primary series

2023 ∙ ATAGI

ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older